MBX Biosciences, Inc. (MBX)

MBX Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	75.29	49.35	30.52	30.52
Short-Term Investments	298.42	212.8	50.15	50.15
Cash & Short-Term Investments	373.71	262.15	80.68	80.68
Cash Growth	42.55%	224.94%	-	-
Other Current Assets	7.83	5.14	2.79	2.79
Total Current Assets	381.54	267.29	83.47	83.47
Net Property, Plant & Equipment	3.22	1.2	0.67	0.67
Other Long-Term Assets	0.38	0.05	0.05	0.05
Total Assets	385.14	268.54	84.18	84.18
Accounts Payable	2.98	5.34	1.39	1.39
Accrued Expenses	12.35	5.55	2.38	2.38
Current Portion of Leases	0.17	0.17	0.15	0.15
Total Current Liabilities	15.5	11.05	3.93	3.93
Long-Term Leases	0.42	-	0.17	0.17
Other Long-Term Liabilities	0	0.04	0.19	0.19
Total Long-Term Liabilities	0.43	0.04	0.37	0.37
Total Liabilities	15.92	11.09	4.29	4.29
Common Stock	0.01	0.01	0	0
Additional Paid-in Capital	593.41	394.89	3.05	3.05
Accumulated Other Comprehensive Income	0.29	0.06	0.06	0.06
Retained Earnings	-224.48	-137.51	-75.58	-75.58
Minority Interest	-	-	152.36	152.36
Shareholders' Equity	369.22	257.44	-72.47	-72.47
Total Liabilities & Equity	385.14	268.54	84.18	84.18
Total Debt	0.6	0.17	0.32	0.32
Net Cash (Debt)	373.11	261.98	80.35	80.35
Net Cash Growth	42.42%	226.04%	-	-
Net Cash Per Share	10.22	24.61	78.87	120.47
Book Value	369.22	257.44	-72.47	-72.47
Book Value Per Share	10.11	24.19	-71.13	-108.64
Tangible Book Value	369.22	257.44	-72.47	-72.47
Tangible Book Value Per Share	10.11	24.19	-71.13	-108.64

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q